Los Gastos Financieros De La Deuda Cambio Fecha
AstraZeneca USD 340M 144M 2026-06
Bayer EUR 675M 87M 2025-12
Essilor EUR 168M 21M 2025-12
Fresenius EUR 81M 5M 2025-09
Fresenius Medical Care EUR 83M 4M 2026-06
GlaxoSmithKline GBP 121M 46M 2026-06
GRIFOLS EUR 141.43M 61.28M 2025-06
Lonza CHF 84M 14M 2025-06
Merck EUR 137M 33M 2026-06
Novartis USD 462M 119M 2026-06
Philips EUR 83M 26M 2026-03
Roche Holding CHF 304M 7.5M 2025-06
Sanofi EUR 287M 109M 2026-06
Smith & Nephew USD 69M 1000K 2025-12
Sonova Holding CHF 24.2M 3.7M 2025-06
UCB EUR 49M 29M 2025-12